Re: E-DRUG: Cost of AZT in developing countries

[Catherine Hodgkin <chodgkin@xs4all.nl>]

E-DRUG: Cost of AZT in developing countries (2)
-----------------------------------------------
Dear Sid,

Have you seen the recent WHO report "The implications of 
antiretroviral treatments" ? This report is a summary of an informal 
consultation in April this year. There are several sections in this 
which deal costs of providing AZT in developing countries under 
different assumptions.  In particular a paper by Katherine Floyd and 
Charles Gilks goes into some detail about the costs of antiretroviral 
therapy in different regions - though it does not give the bulk costs 
in the way you require. Figures from Uraguay quoted in this report 
says that the cost of AZT bought in bulk has been reduced to
approximately 28% of US market prices.(The person to contact at WHO, 
I think, would be Erik van Praag who edited this report and has done 
a lot of work in this area.)

You may be able to get this info from the Price Indicator which 
Management Sciences for Health (MSH) is presently updating.
Regards,

Catherine Hodgkin
Amsterdam
The Netherlands
Email: chodgkin@xs4all.nl

Notes from the moderator:
-------------
1. The publication "International Drug Price Indicator Guide" 1996 
edition can be obtained free of charge from MSH. Please contact
Serena Parker, MSH, 1655 N. Ft. Myer Drive, #920, Arlington, 
VA 22209, USA, Phone: 1-703-524-7689. Email: sparker@msh-dc.org 
http://www.msh.org

2. Please state your name, affiliation, and mailing address etc. 
when you post any messages to E-DRUG. Thanks.

Syed Rizwanuddin Ahmad

--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.